Antiviral Therapy [topp]    
PREVENT [phsu]    
HEPATOCELLULAR CARCINOMA [neop]    
Chronic infection [dsyn]    
HCV [virs]    
HEPATOCELLULAR CARCINOMA [neop]    
Risk Factors [qnco]    
Related [qlco]    
HEPATOCELLULAR CARCINOMA [neop]    
Persistent [tmco]    
HEPATITIS B E ANTIGEN [imft]    
SERUM [bdsu]    
Levels [qlco]    
CIRRHOSIS [dsyn]    
Risk Factor [qnco]    
HCV [virs]    
Related [qlco]    
HEPATOCELLULAR CARCINOMA [neop]    
CIRRHOSIS [dsyn]    
Randomized [resa]    
DOUBLE BLIND [resa]    
Controlled Trial [resa]    
Patients [podg]    
HEPATITIS B E ANTIGEN [imft]    
SERUM [bdsu]    
Levels [qlco]    
Antiviral Therapy [topp]    
PREVENT [phsu]    
Disease Progression [patf]    
Reduced [qlco]    
HEPATOCELLULAR CARCINOMA [neop]    
Antiviral Therapy [topp]    
HEPATOCELLULAR CARCINOMA [neop]    
COHORT STUDIES [qnco]    
meta-analyses [resa]    
Several [qnco]    
Patients [podg]    
HCV [virs]    
Related [qlco]    
CIRRHOSIS [dsyn]    
Treated [ftcn]    
Patients [podg]    
LOWER [spco]    
HEPATOCELLULAR CARCINOMA [neop]    
Greater [qnco]    
Observed [ftcn]    
Patients [podg]    
SUSTAINED VIROLOGIC RESPONSE [fndg]    
Benefit [qnco]    
Antiviral Therapy [topp]    
HEPATITIS B [dsyn]    
Hepatitis C [dsyn]    
PREVENT [phsu]    
Completely [qlco]    
HEPATOCELLULAR CARCINOMA [neop]    
Improvement [cnce]    
Identification [menp]    
Infected [fndg]    
Persons [popg]    
accessibility [qlco]    
Care [acty]    
affordability [qnco]    
treatment [ftcn]    
Needed [qlco]    
Antiviral Therapy [topp]    
IMPACT [gngm]    
Global [spco]    
HEPATOCELLULAR CARCINOMA [neop]    
